Related references
Note: Only part of the references are listed.In vitro efficacy of forodesine and nelarabine (ara-G) in pediatric leukemia
Irene Homminga et al.
BLOOD (2011)
Induction of fetal hemoglobin and ABCB1 gene expression in 9-β-D-arabinofuranosylguanine-resistant MOLT-4 cells
Anna Fyrberg et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Deoxycytidine Kinase Modulates the Impact of the ABC Transporter ABCG2 on Clofarabine Cytotoxicity
Shinjiro Nagai et al.
CANCER RESEARCH (2011)
Contribution of Abcc10 (Mrp7) to In Vivo Paclitaxel Resistance as Assessed in Abcc10-/- Mice
Elizabeth A. Hopper-Borge et al.
CANCER RESEARCH (2011)
ABC Multidrug Transporters: Target for Modulation of Drug Pharmacokinetics and Drug-Drug Interactions
Beatrice Marquez et al.
CURRENT DRUG TARGETS (2011)
The Challenge of Exploiting ABCG2 in the Clinic
Robert W. Robey et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Role of organic cation transporters in drug-induced toxicity
Giuliano Ciarimboli
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2011)
Analysis of Three-dimensional Systems for Developing and Mature Kidneys Clarifies the Role of OAT1 and OAT3 in Antiviral Handling
Megha A. Nagle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Tenofovir renal proximal tubular toxicity is regulated By OAT1 and MRP4 transporters
James J. Kohler et al.
LABORATORY INVESTIGATION (2011)
Antiviral Drugs for Viruses Other Than Human Immunodeficiency Virus
Raymund R. Razonable
MAYO CLINIC PROCEEDINGS (2011)
Cytarabine Dose for Acute Myeloid Leukemia
Bob Löwenberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Variability in transport and biotransformation of cytarabine is associated with its toxicity in peripheral blood mononuclear cells
Sumit Parmar et al.
PHARMACOGENOMICS (2011)
Nucleoside reverse transcriptase inhibitor toxicity and mitochondrial DNA
Christopher A. Koczor et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2010)
Expression of the human concentrative nucleotide transporter 1 (hCNT1) gene correlates with clinical response in patients affected by Waldenstrom's Macroglobulinemia (WM) and small lymphocytic lymphoma (SLL) undergoing a combination treatment with 2-chloro-2′-deoxyadenosine (2-CdA) and Rituximab
C. Rabascio et al.
LEUKEMIA RESEARCH (2010)
Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier
David S. Miller
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Transport of Nucleoside Analogs Across the Plasma Membrane: A Clue to Understanding Drug-Induced Cytotoxicity
I. Huber-Ruano et al.
CURRENT DRUG METABOLISM (2009)
Clinical pharmacology and pharmacogenetics of gemcitabine
Andrea Wong et al.
DRUG METABOLISM REVIEWS (2009)
Expression of Organic Cation Transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) Is Affected by Genetic Factors and Cholestasis in Human Liver
Anne T. Nies et al.
HEPATOLOGY (2009)
Murine cardiac mtDNA: effects of transgenic manipulation of nucleoside phosphorylation
James J. Kohler et al.
LABORATORY INVESTIGATION (2009)
Tenofovir renal toxicity targets mitochondria of renal proximal tubules
James J. Kohler et al.
LABORATORY INVESTIGATION (2009)
Transgenic mitochondrial superoxide dismutase and mitochondrially targeted catalase prevent antiretroviral-induced oxidative stress and cardiomyopathy
James J. Kohler et al.
LABORATORY INVESTIGATION (2009)
Cardiac-targeted transgenic mutant mitochondrial enzymes: MtDNA defects, antiretroviral toxicity and cardiomyopathy
James J. Kohler et al.
CARDIOVASCULAR TOXICOLOGY (2008)
Mitochondrial DNA impairment in nucleoside reverse transcriptase inhibitor-associated cardiomyopathy
James J. Kohler et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Relevance of the organic cation transporters 1 and 2 for antiretroviral drug therapy in human immunodeficiency virus infection
Norma Jung et al.
DRUG METABOLISM AND DISPOSITION (2008)
Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides
Cornelia de Wolf et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules
Frans G. M. Russel et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
SLC28 genes and concentrative nucleoside transporter (CNT) proteins
M. Pastor-Anglada et al.
XENOBIOTICA (2008)
Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins
J. D. Young et al.
XENOBIOTICA (2008)
Ribavirin uptake by cultured human choriocarcinoma (BeWo) cells and Xenopus laevis oocytes expressing recombinant plasma membrane human nucleoside transporters
Takashi Yamamoto et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
In vitro cytotoxicity and mitochondrial toxicity of tenofovir alone and in combination with other antiretrovirals in human renal proximal tubule cells
Francesc Vidal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Mechanism of active renal tubular efflux of tenofovir
Adrian S. Ray et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH
Kay Barnes et al.
CIRCULATION RESEARCH (2006)
Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA:: evidence supporting the DNA pol γ hypothesis
W Lewis et al.
AIDS (2006)
Transgenic expression of the deoxynucleotide carrier causes mitochondrial damage that is enhanced by NRTIs for AIDS
W Lewis et al.
LABORATORY INVESTIGATION (2005)
Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies
J Kurtzberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes
SA Baldwin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Expression of deoxynucleotide carrier is not associated with the mitochondrial DNA depletion caused by anti-HIV dideoxynucleoside analogs and mitochondrial dNTP uptake
W Lam et al.
MOLECULAR PHARMACOLOGY (2005)
The potential impact of drug transporters on nucleoside-analog-based antiviral chemotherapy
P Borst et al.
ANTIVIRAL RESEARCH (2004)
Mitochondrial expression of the human equilibrative nucleoside transporter 1 (hENT1) results in enhanced mitochondrial toxicity of antiviral drugs
YR Lai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Mrp4 confers resistance to topotecan and protects the brain from chemotherapy
M Leggas et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Uridine recognition motifs of human equilibrative nucleoside transporters 1 and 2 produced in Saccharomyces cerevisiae
MF Vickers et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2004)
Mitochondrial toxicity of NRTI antiviral drugs: An integrated cellular perspective
W Lewis et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
The novel nucleoside transport system exhibited by NB4 cells, csg, transports deoxyguanosine analogues, including ara-G
SA Flanagan et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
AH Schinkel et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML)
MM van den Heuvel-Eibrink et al.
LEUKEMIA (2002)
Transport of antiviral 3′-deoxy-nucleoside drugs by recombinant human and rat equilibrative, nitrobenzylthioinosine (NBMPR)-insensitive (ENT2) nucleoside transporter proteins produced in Xenopus oocytes
SYM Yao et al.
MOLECULAR MEMBRANE BIOLOGY (2001)
Cladribine in the treatment of chronic lymphocytic leukemia
T Robak
LEUKEMIA & LYMPHOMA (2001)
Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib)
MWL Ritzel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs
T Cihlar et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2001)
Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.
KR Rai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells - ENT2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine
JL Ward et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Differential transport of cytosine-containing nucleosides by recombinant human concentrative nucleoside transporter protein hCNT1.
KA Graham et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2000)
Share Paper
